US2086186A
(en)
|
1933-10-10 |
1937-07-06 |
Us Rubber Co |
Treatment of rubber
|
SU50906A1
(ru)
|
1935-12-20 |
1936-11-30 |
А.И. Бурляев |
Веретено дл пр дильных машин
|
GB1435721A
(en)
|
1972-05-18 |
1976-05-12 |
Lilly Industries Ltd |
Benzoxazole derivatives
|
US4675332A
(en)
|
1984-12-10 |
1987-06-23 |
Warner-Lambert Company |
Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
|
GB8610981D0
(en)
|
1986-05-06 |
1986-06-11 |
Ici America Inc |
Quinoline amides
|
NZ225045A
(en)
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
BR9106193A
(pt)
|
1990-10-22 |
1993-03-23 |
Bausch & Lomb |
Metodo e composicao para limpar lentes de contato
|
AU641052B2
(en)
|
1990-11-02 |
1993-09-09 |
Aventisub Ii Inc. |
3-amidoindolyl derivatives
|
US5668117A
(en)
|
1991-02-22 |
1997-09-16 |
Shapiro; Howard K. |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
US6444221B1
(en)
|
1992-06-30 |
2002-09-03 |
Howard K. Shapiro |
Methods of treating chronic inflammatory diseases using carbonyl trapping agents
|
US5472954A
(en)
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
TW401300B
(en)
|
1992-12-25 |
2000-08-11 |
Senju Pharma Co |
Antiallergic composition for ophthalmic or nasal use
|
US5493027A
(en)
|
1993-01-22 |
1996-02-20 |
Board Of Regents, The University Of Texas System |
Anticonvulsive agents and uses thereof
|
US5767109A
(en)
|
1993-10-20 |
1998-06-16 |
Sanchez; Robert A. |
Complexing urushiols
|
US5576311A
(en)
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
JP3297969B2
(ja)
|
1994-12-26 |
2002-07-02 |
ライオン株式会社 |
点眼剤
|
US5597823A
(en)
|
1995-01-27 |
1997-01-28 |
Abbott Laboratories |
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
|
JP3736916B2
(ja)
|
1996-02-19 |
2006-01-18 |
株式会社サンコンタクトレンズ |
含水性ソフトコンタクトレンズの消毒用組成物とその用途
|
JP2001508029A
(ja)
|
1996-08-01 |
2001-06-19 |
ダウ・アグロサイエンス・エル・エル・シー |
殺菌・殺カビ活性を有する4―置換キノリン誘導体
|
EP0920429B1
(fr)
|
1996-08-06 |
2003-02-19 |
Pfizer Inc. |
Derives 6,6- ou 6,7-bicycliques contenant pyrido ou pyrimido substitues
|
DE59813690D1
(de)
|
1997-05-02 |
2006-09-28 |
Schering Ag |
Substituierte heterocyclen und deren verwendung in arzneimitteln
|
GB2327672A
(en)
|
1997-07-23 |
1999-02-03 |
Merck & Co Inc |
4-(1,2,3,4-Tetrahydro-1,8-naphthyridin-7-yl)butanoyl-glycyl-3(S)-quinolin-3-yl-beta-alanine
|
EP1012151B1
(fr)
|
1997-09-02 |
2002-08-07 |
Bristol-Myers Squibb Pharma Company |
Pyridines a cycle fusionne et a substitution heterocyclyle, antagonistes du facteur de liberation de la cortitropine (crf), utiles dans le traitement des troubles lies au snc et au stress
|
JP2004500308A
(ja)
|
1998-03-12 |
2004-01-08 |
ノボ ノルディスク アクティーゼルスカブ |
プロテインチロシンホスアターゼのモジュレーター
|
US6498154B1
(en)
|
1999-05-04 |
2002-12-24 |
Wyeth |
Cyclic regimens using quinazolinone and benzoxazine derivatives
|
US6358948B1
(en)
|
1999-05-04 |
2002-03-19 |
American Home Products Corporation |
Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
|
JP3568108B2
(ja)
|
1999-07-28 |
2004-09-22 |
松下電器産業株式会社 |
デジタル地図の位置情報伝達方法とそれを実施する装置
|
AU1657001A
(en)
|
1999-11-15 |
2001-05-30 |
Smithkline Beecham Corporation |
Carvedilol methanesulfonate
|
AU1735001A
(en)
|
1999-12-10 |
2001-06-18 |
Senju Pharmaceutical Co., Ltd. |
Cyclodextrin-containing pharmaceutical composition
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
JP4748289B2
(ja)
|
2000-06-23 |
2011-08-17 |
ライオン株式会社 |
点眼剤、眼科用組成物及び吸着抑制方法
|
FR2827599A1
(fr)
|
2001-07-20 |
2003-01-24 |
Neuro3D |
Composes derives de quinoleine et quinoxaline,preparation et utilisations
|
UA83620C2
(ru)
|
2001-12-05 |
2008-08-11 |
Уайт |
Замещенные бензоксазолы и их аналоги как эстрогенные агенты
|
US20060014786A1
(en)
|
2002-05-17 |
2006-01-19 |
Rajeev Raut |
Opthalmic pharmaceutical compositions and methods for treating ocular inflammation
|
CA2451267A1
(fr)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Utilisations pharmaceutiques de ligands alpha2delta
|
US20040198828A1
(en)
|
2003-01-17 |
2004-10-07 |
Abelson Mark B. |
Combinational use of long-acting and short-acting anti-histamines for ocular allergies
|
US20040242704A1
(en)
|
2003-03-14 |
2004-12-02 |
University Of Washington, Techtransfer - Invention Licensing |
Stabilized mutant opsin proteins
|
DE602004030103D1
(de)
|
2003-04-18 |
2010-12-30 |
Advanced Medicine Res Inst |
Mittel zur behanldung von krankheiten zur aufbringung auf das auge
|
US20060111318A1
(en)
|
2003-04-18 |
2006-05-25 |
Advanced Medicine Research Institute |
Agent for treating eye diseases
|
US7297709B2
(en)
|
2003-05-22 |
2007-11-20 |
Abbott Laboratories |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
US20040235892A1
(en)
|
2003-05-22 |
2004-11-25 |
Yujia Dai |
Indazole and benzisoxazole kinase inhibitors
|
US7083803B2
(en)
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US7563906B2
(en)
|
2003-10-15 |
2009-07-21 |
Ube Industries, Ltd. |
Indazole derivatives
|
EP1678160A1
(fr)
|
2003-10-27 |
2006-07-12 |
Astellas Pharma Inc. |
Derives de pyrazine et utilisation pharmaceutique de ce derive
|
EP1689397A4
(fr)
|
2003-11-20 |
2007-06-20 |
Othera Pharmaceuticals Inc |
Amelioration de la degenerescence maculaire et d'autres maladies ophtalmiques
|
US20050197292A1
(en)
|
2004-01-30 |
2005-09-08 |
Glennda Smithson |
Compositions and methods for treating T-cell mediated pathological conditions
|
EP1722766A2
(fr)
|
2004-02-17 |
2006-11-22 |
President And Fellows Of Harvard College |
Gestion de troubles ophtalmologiques, notamment la degenerescence maculaire
|
US20050234018A1
(en)
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
WO2006002473A1
(fr)
|
2004-07-02 |
2006-01-12 |
Adelaide Research & Innovation Pty Ltd |
Procédé de controle de dommages causés par des aldéhydes alpha, béta-insaturés
|
US20070287716A1
(en)
|
2004-10-28 |
2007-12-13 |
Hu Essa H |
Pyrimidine and Quinoline Potentiators of Metabotropic Glutamate Receptors
|
EP1844768A1
(fr)
|
2005-01-19 |
2007-10-17 |
Dainippon Sumitomo Pharma Co., Ltd. |
Dérivé de sulfone aromatique en tant que régulateur de récepteur de l'aldostérone
|
TW200640443A
(en)
|
2005-02-23 |
2006-12-01 |
Alcon Inc |
Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
|
EP1893174A2
(fr)
|
2005-05-10 |
2008-03-05 |
Cytophil, Inc. |
Hydrogels injectables et leurs procedes de fabrication et d'utilisation
|
ES2393768T3
(es)
*
|
2005-05-26 |
2012-12-27 |
Neuron Systems, Inc |
Derivado de quinolina para el tratamiento de enfermedades retinianas
|
CN101351199B
(zh)
|
2005-12-27 |
2013-01-02 |
狮王株式会社 |
软性接触镜用组合物及吸附抑制方法
|
US7842312B2
(en)
|
2005-12-29 |
2010-11-30 |
Cordis Corporation |
Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
|
JP4466875B2
(ja)
|
2006-04-05 |
2010-05-26 |
ライオン株式会社 |
ソフトコンタクトレンズ用点眼剤
|
ZA200809493B
(en)
|
2006-04-14 |
2010-08-25 |
Prana Biotechnology Ltd |
Method of treatment of age-related macular degeneration (AMD)
|
JP5194218B2
(ja)
|
2006-06-05 |
2013-05-08 |
株式会社メニコンネクト |
含水性コンタクトレンズの保存方法ならびに該保存方法により保存された含水性コンタクトレンズ
|
EP2079699A1
(fr)
|
2006-07-25 |
2009-07-22 |
Envivo Pharmaceuticals, Inc. |
Dérivés de quinoline
|
US8158609B1
(en)
|
2006-11-02 |
2012-04-17 |
Novartis Ag |
Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
|
US20080241256A1
(en)
|
2007-03-30 |
2008-10-02 |
Liisa Kuhn |
Targeted active agent delivery system based on calcium phosphate nanoparticles
|
TW201242961A
(en)
|
2007-06-20 |
2012-11-01 |
Ironwood Pharmaceuticals Inc |
FAAH inhibitors
|
RU2014151622A
(ru)
|
2007-10-05 |
2015-08-20 |
Акусела Инк. |
Композиции и способы лечения нейродегенеративных заболеваний
|
US8324270B2
(en)
|
2008-02-11 |
2012-12-04 |
University Of Washington |
Methods for the treatment and prevention of age-related retinal dysfunction
|
KR20110044291A
(ko)
|
2008-08-12 |
2011-04-28 |
서트리스 파마슈티컬즈, 인코포레이티드 |
시르투인 조절제로서의 벤족사졸, 벤즈티아졸 및 관련 유사체
|
TWI486326B
(zh)
|
2008-10-22 |
2015-06-01 |
Acucela Inc |
用於治療眼疾和眼病變之連接氮之化合物
|
WO2010107525A1
(fr)
|
2009-03-17 |
2010-09-23 |
Aciex Therapeutics, Inc. |
Formulations ophtalmiques de kétotifène et procédés d'utilisation
|
WO2010133672A1
(fr)
|
2009-05-20 |
2010-11-25 |
Clanotech Ab |
Dérivés d'acide quinoléine-3-carboxylique et leur utilisation médicale
|
WO2010148351A1
(fr)
|
2009-06-18 |
2010-12-23 |
Cylene Pharmaceuticals, Inc. |
Rhodanines et hétérocycles associés en tant qu'inhibiteurs de kinase
|
EP2477594A4
(fr)
|
2009-07-15 |
2013-03-13 |
Univ Vanderbilt |
Piégeurs d isokétal et réduction des troubles impliquant une lésion oxydative
|
TWI492769B
(zh)
|
2009-09-23 |
2015-07-21 |
Alcon Res Ltd |
可注射的水性眼用組成物及其使用之方法
|
WO2011071995A2
(fr)
|
2009-12-08 |
2011-06-16 |
Case Western Reserve University |
Composés et procédés de traitement de troubles oculaires
|
CA2782015C
(fr)
|
2009-12-11 |
2020-08-25 |
Neuron Systems, Inc. |
Compositions ophthalmiques topiques et methodes de traitement de la degenerescence maculaire
|
WO2011078204A1
(fr)
|
2009-12-24 |
2011-06-30 |
浜理薬品工業株式会社 |
Agent prophylactique ou thérapeutique destiné à une hyperlipémie et agent anti-fatigue
|
WO2011116066A1
(fr)
*
|
2010-03-17 |
2011-09-22 |
Concert Pharmaceuticals, Inc. |
Dérivés de diméthylcurcumine
|
PL2663550T4
(pl)
|
2011-01-12 |
2017-07-31 |
Ventirx Pharmaceuticals, Inc. |
Podstawione benzoazepiny jako modulatory receptora toll-podobnego
|
US10463687B2
(en)
|
2011-01-20 |
2019-11-05 |
Cornell University |
Treatments for retinal disorders
|
CN103442735B
(zh)
|
2011-01-31 |
2016-11-09 |
特米拉公司 |
用于减轻技术领域中所不希望的医学状况的有效要素
|
TWI544922B
(zh)
|
2011-05-19 |
2016-08-11 |
愛爾康研究有限公司 |
高濃度歐羅派特錠(olopatadine)眼用組成物
|
US20130190500A1
(en)
*
|
2011-12-12 |
2013-07-25 |
Neuron Systems, Inc. |
Process to prepare 6-chloro-3-amino-2-(2-hydroxypropyl)-1-azanaphthalene
|
US20130165419A1
(en)
|
2011-12-21 |
2013-06-27 |
Insite Vision Incorporated |
Combination anti-inflammatory ophthalmic compositions
|
NZ703992A
(en)
|
2012-08-01 |
2018-04-27 |
Lewis And Clark Pharmaceuticals Inc |
N-alkyl 2-(disubstituted)alkynyladenosine-5’-uronamides as a2a agonists
|
AU2013342275B2
(en)
|
2012-11-08 |
2017-11-09 |
Clearside Biomedical, Inc. |
Methods and devices for the treatment of ocular diseases in human subjects
|
RU2015120478A
(ru)
*
|
2012-12-20 |
2017-01-25 |
Альдейра Терапьютикс, Инк. |
Пери-карбинолы
|
KR102435676B1
(ko)
|
2013-01-23 |
2022-08-24 |
알데이라 테라퓨틱스, 아이엔씨. |
독성 알데히드 관련된 질병 및 치료
|
TWI624262B
(zh)
|
2013-01-23 |
2018-05-21 |
桑紐爾製藥公司 |
醫藥配方
|
US10111862B2
(en)
|
2013-01-25 |
2018-10-30 |
Aldeyra Therapeutics, Inc. |
Traps in the treatment of macular degeneration
|
US9713330B1
(en)
*
|
2013-03-15 |
2017-07-25 |
Deuteria Agrochemicals, Llc |
Deuterium-enriched aldehydes
|
US10272106B2
(en)
|
2014-06-04 |
2019-04-30 |
Case Western Reserve University |
Compositions and methods of treating diabetic retinopathy
|
NO2721710T3
(fr)
|
2014-08-21 |
2018-03-31 |
|
|
WO2016036674A1
(fr)
*
|
2014-09-02 |
2016-03-10 |
Bhupinder Singh |
Molécule deutérée ou non-deutérée et formulations pharmaceutiques
|
WO2016085939A2
(fr)
|
2014-11-24 |
2016-06-02 |
Case Western Reserve University |
Composés et méthodes de traitement de troubles oculaires
|
AU2016311158A1
(en)
|
2015-08-21 |
2018-04-05 |
Aldeyra Therapeutics, Inc. |
Deuterated compounds and uses thereof
|
KR20180073553A
(ko)
|
2015-08-21 |
2018-07-02 |
알데이라 테라퓨틱스, 아이엔씨. |
알데히드 접합체 및 이의 용도
|
EP3419633A4
(fr)
|
2016-02-28 |
2019-10-30 |
Aldeyra Therapeutics, Inc. |
Traitement des pathologies oculaires allergiques avec des cyclodextrines
|
EP3454858A4
(fr)
|
2016-05-09 |
2020-01-15 |
Aldeyra Therapeutics, Inc. |
Polythérapie de troubles et de maladies inflammatoires oculaires
|
WO2018039197A1
(fr)
|
2016-08-22 |
2018-03-01 |
Aldeyra Therapeutics, Inc. |
Composés de piégeage d'aldéhydes et leurs procédés d'utilisation
|
EP3500256A4
(fr)
|
2016-08-22 |
2020-01-08 |
Aldeyra Therapeutics, Inc. |
Composés de piégeage d'aldéhydes et leurs utilisations
|
JP2020511461A
(ja)
|
2017-03-16 |
2020-04-16 |
アルデイラ セラピューティクス, インコーポレイテッド |
多形化合物およびその使用
|
AU2018348174A1
(en)
|
2017-10-10 |
2020-04-23 |
Aldeyra Therapeutics, Inc. |
Treatment of inflammatory disorders
|
WO2020018498A1
(fr)
|
2018-07-16 |
2020-01-23 |
Aldeyra Therapeutics, Inc. |
Formulations de cyclodextrine
|
WO2020028820A1
(fr)
|
2018-08-03 |
2020-02-06 |
Aldeyra Therapeutics, Inc. |
Compositions topiques et procédés de préparation et d'utilisation
|
JP2021533154A
(ja)
|
2018-08-06 |
2021-12-02 |
アルデイラ セラピューティクス, インコーポレイテッド |
多形化合物およびその使用
|
CN113056353B
(zh)
|
2018-09-25 |
2022-11-01 |
奥尔德拉医疗公司 |
用于治疗干眼病的调配物
|
WO2020072621A1
(fr)
|
2018-10-02 |
2020-04-09 |
Aldeyra Therapeutics, Inc. |
Solutions pour lentilles de contact et kits
|
WO2020198064A1
(fr)
|
2019-03-26 |
2020-10-01 |
Aldeyra Therapeutics, Inc. |
Formulations ophtalmiques et leurs utilisations
|
WO2020223717A1
(fr)
|
2019-05-02 |
2020-11-05 |
Aldeyra Therapeutics, Inc. |
Procédé de préparation d'un piégeur d'aldéhyde et d'intermédiaires
|
CN113784954A
(zh)
|
2019-05-02 |
2021-12-10 |
奥尔德拉医疗公司 |
多晶型化合物和其用途
|